Last week, we announced the publication of Phase 3 ECOSPOR III study data in the New England Journal of Medicine highlighting SER-109, an investigational oral #microbiome therapeutic for recurrent #Cdiff infection. Learn more: https://t.co/qbOA4VgZEF #ICYMI
N95 masks are arriving at grocery stores and pharmacies this week, and consumers will be able to pick them up for free while supplies last.
https://t.co/L0HP2KrWh2
🎉Congrats to our 2021-23 Forward Program Scholars! These early career physician-scientists will participate in a training and mentorship program designed to provide concrete and applicable skills. #EquityinGI https://t.co/31nEBuAtWH @MuyiwaAwoniyi1@ManuelBragaMD @JBenhammouMD
In the 📕#RedJournal:
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls
Caldera, et al.
👉 https://t.co/3d8J8iBJRA
#gastroenterology@dr_fcalderaibd @mshayney @FarrayeIBD
We are proud to be the global sponsor of @cdiffFoundation’s C. diff Patient, Family, Caregiver Online Symposium on January 28! Register today for this special live online event: https://t.co/cVndqSGqg6 #FerringMicrobiome
Clorox Healthcare Sr. Infection Preventionist @DoeKley_RN_MPH discusses the 5 Rights of Cleaning and Disinfection, a new format that can help establish an effective #cleaning and #disinfecting program, in this blog post: https://t.co/Ty7c29ScPP
Earlier this month, we presented a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference. #ICYMI, watch the webcast replay today: https://t.co/DPWcaK580P #JPM22#JPM2022
We are collaborating with Cyprumed GmbH on the development of next generation formulation technology for non-invasive delivery of biologics.
Learn more:https://t.co/YCTMPKcBYz
Clorox has been a proud partner of The San Francisco @49ers this 2021-2022 football season, working to provide a cleaner + safer environment for faithful fans that attended home games at @LevisStadium. Best of luck in today's divisional playoff game! #GoNiners